Dowsett M - Search Results

1

Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.

Almendro V, Cheng YK, Randles A, Itzkovitz S, Marusyk A, Ametller E, Gonzalez-Farre X, Muñoz M, Russnes HG, Helland A, Rye IH, Borresen-Dale AL, Maruyama R, van Oudenaarden A, Dowsett M, Jones RL, Reis-Filho J, Gascon P, Gönen M, Michor F, Polyak K. Almendro V, et al. Among authors: dowsett m. Cell Rep. 2014 Feb 13;6(3):514-27. doi: 10.1016/j.celrep.2013.12.041. Epub 2014 Jan 23. Cell Rep. 2014. PMID: 24462293 Free PMC article.

2

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer.

Jones RL, Salter J, A'Hern R, Nerurkar A, Parton M, Reis-Filho JS, Smith IE, Dowsett M. Jones RL, et al. Among authors: dowsett m. Breast Cancer Res Treat. 2009 Jul;116(1):53-68. doi: 10.1007/s10549-008-0081-7. Epub 2008 Jul 1. Breast Cancer Res Treat. 2009. PMID: 18592370

3

Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer.

Jones RL, Salter J, A'Hern R, Nerurkar A, Parton M, Reis-Filho JS, Smith IE, Dowsett M. Jones RL, et al. Among authors: dowsett m. Breast Cancer Res Treat. 2010 Jan;119(2):315-23. doi: 10.1007/s10549-009-0329-x. Epub 2009 Feb 27. Breast Cancer Res Treat. 2010. PMID: 19247830

4

Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancer.

Jones RL, Rojo F, A'Hern R, Villena N, Salter J, Corominas JM, Servitja S, Smith IE, Rovira A, Reis-Filho JS, Dowsett M, Albanell J. Jones RL, et al. Among authors: dowsett m. J Clin Pathol. 2011 Feb;64(2):130-5. doi: 10.1136/jcp.2010.082966. Epub 2010 Dec 8. J Clin Pathol. 2011. PMID: 21148141

5

Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer.

Sheri A, Smith IE, Hills M, Jones RL, Johnston SR, Dowsett M. Sheri A, et al. Among authors: dowsett m. Breast Cancer Res Treat. 2017 Jul;164(2):395-400. doi: 10.1007/s10549-017-4266-9. Epub 2017 Apr 26. Breast Cancer Res Treat. 2017. PMID: 28447240 Free PMC article.

6

Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy.

Pierga JY, Reis-Filho JS, Cleator SJ, Dexter T, Mackay A, Simpson P, Fenwick K, Iravani M, Salter J, Hills M, Jones C, Ashworth A, Smith IE, Powles T, Dowsett M. Pierga JY, et al. Among authors: dowsett m. Br J Cancer. 2007 Jan 29;96(2):341-51. doi: 10.1038/sj.bjc.6603483. Epub 2006 Nov 28. Br J Cancer. 2007. PMID: 17133270 Free PMC article.

7

Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy.

Sheri A, Smith IE, Johnston SR, A'Hern R, Nerurkar A, Jones RL, Hills M, Detre S, Pinder SE, Symmans WF, Dowsett M. Sheri A, et al. Among authors: dowsett m. Ann Oncol. 2015 Jan;26(1):75-80. doi: 10.1093/annonc/mdu508. Epub 2014 Oct 30. Ann Oncol. 2015. PMID: 25361988 Free article.

8

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.

Ellis PA, Lonning PE, Borresen-Dale A, Aas T, Geisler S, Akslen LA, Salter I, Smith IE, Dowsett M. Ellis PA, et al. Among authors: dowsett m. Br J Cancer. 1997;76(4):480-5. doi: 10.1038/bjc.1997.413. Br J Cancer. 1997. PMID: 9275025 Free PMC article.

9

Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer.

Arnedos M, Drury S, Afentakis M, A'Hern R, Hills M, Salter J, Smith IE, Reis-Filho JS, Dowsett M. Arnedos M, et al. Among authors: dowsett m. Ann Oncol. 2014 Mar;25(3):605-610. doi: 10.1093/annonc/mdt575. Epub 2014 Feb 12. Ann Oncol. 2014. PMID: 24525703 Free PMC article.

10

Screening for ESR mutations in breast and ovarian cancer patients.

Anderson TI, Wooster R, Laake K, Collins N, Warren W, Skrede M, Elles R, Tveit KM, Johnston SR, Dowsett M, Olsen AO, Møller P, Stratton MR, Børresen-Dale AL. Anderson TI, et al. Among authors: dowsett m. Hum Mutat. 1997;9(6):531-6. doi: 10.1002/(SICI)1098-1004(1997)9:6<531::AID-HUMU6>3.0.CO;2-4. Hum Mutat. 1997. PMID: 9195227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

737 results

Search Page